webinar register page

Webinar banner
Micron Medical Key Opinion Leaders Webinars on Protect PNS for OAB: A Percutaneous Wireless Micro-Neurostimulation Technology


Dec 9, 2020 10:30 AM

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Larry Sirls, MD
@Beaumont Health
Larry Sirls, MD graduated from the University of Michigan Medical School and completed urology residency training at Henry Ford Hospital. He completed specialty fellowship training in Male and Female Pelvic Reconstructive Surgery, Urodynamics, Female Urology, and Neurourology at Kaiser Permanente Medical Center in Los Angeles. He returned to Detroit in 1993 and has practiced exclusively at Beaumont Hospital Royal Oak since 1996.
Kenneth Peters, MD
@Beaumont Health
Kenneth Peters, MD, is Chair of Urology at Beaumont Health System in Royal Oak, Michigan, and Medical Director of the Beaumont Women’s Urology Center in Royal Oak, a unique multidisciplinary center dedicated to women with chronic pelvic pain and voiding dysfunction. Dr. Peters is also Professor and Chair of Urology at the Oakland University William Beaumont School of Medicine in Rochester, Michigan. He graduated with honors from the University of Michigan in Ann Arbor and earned his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio.
Mark Landy
Chairman & CEO @Micron Medical
Prior to joining Micron Medical, Dr. Landy served in increasingly senior positions at MiMedx, which develops and markets regenerative and therapeutic biologics utilizing human placental tissue allografts, including most recently as Executive Vice President & Chief Strategy Officer. In this role, he led multiple functions, including market access, R&D, regulatory affairs, quality and regulatory assurance, international, marketing, and business development. He was instrumental in leading the company’s 5-year strategic planning process, organization realignment, capital raise and paving the way for resolution with regulatory authorities.